Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit and Disruptive Behavior Disorders

Explore clinical trials studying Attention Deficit and Disruptive Behavior Disorders. Study availability and eligibility vary by location and protocol.

1,451 public trials 169 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit and Disruptive Behavior Disorders trial results

Completed

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

NCT00997984

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Peninsula Research Associates, Inc. Rolling Hills Estates, California, United States
  • Psychiatric centers at San Diego, Feighner Research San Diego, California, United States
View all 46 locations
View Trial Details
Completed

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

NCT01552915

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Melmed Center Scottsdale, Arizona, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Synergy Clinical Research Center National City, California, United States
  • Pacific Clinical Research Medical Group Orange, California, United States
View all 79 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder

NCT02402166

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • AVIDA Newport Beach, California, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
  • Center For Psychiatry and Behavioral Medicine In Las Vegas, Nevada, United States
  • Duke Child and Family Center Durham, North Carolina, United States
View Trial Details
Completed

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT03260205

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Harmonex, Inc Dothan, Alabama, United States
  • Preferred Research Partners, Inc Little Rock, Arkansas, United States
  • CMB Clinical Trials Colton, California, United States
  • Sun Valley Research Center Imperial, California, United States
View all 48 locations
View Trial Details
Completed

Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)

NCT02604407

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Pharmacology Research Institute Encino, California, United States
  • Pharmacology Research Institute (Pri) Los Alamitos, California, United States
  • Pharmacology Research Institute (Pri) Newport Beach, California, United States
  • Nrc Research Institute Orange, California, United States
View all 45 locations
View Trial Details
Completed

Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT02466425

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Nrc Research Institute Orange, California, United States
  • Pcsd Feighner Research San Diego, California, United States
  • Encompass Clinical Research Spring Valley, California, United States
View all 36 locations
View Trial Details
Completed

Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years

NCT03325881

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • PEWMD, PA, ARCSM, PLLC, PRP, Inc. Little Rock, Arkansas, United States
  • Advanced Research Center Anaheim, California, United States
  • Riverside Medical Clinic Riverside, California, United States
View all 41 locations
View Trial Details
Completed

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

NCT00557960

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Washington Neuropsychological Institute, LLC Washington D.C., District of Columbia, United States
View Trial Details

Related conditions